European Commission Approves Janssen’s Multiple Myeloma Treatment Darzalex (Daratumumab)
The European Commission (EC) has granted provisional approval to Janssen’s Darzalex (daratumumab) as a monotherapy for the treatment of patients with multiple myeloma who…